Medtronic MDT Net proceeds from sales of subsidiary shares
Net proceeds from sales of subsidiary shares at other companies
Other financials
Where this comes from
Reported directly by Medtronic in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceInitialPublicOffering.
The official record: Medtronic’s 10-K, filed June 18, 2026, on SEC EDGAR. View the filing →
Ask your AI about Medtronic's net proceeds from sales of subsidiary shares.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Medtronic's net proceeds from sales of subsidiary shares?
- Medtronic (MDT) reported net proceeds from sales of subsidiary shares of $134.5M in Q1 2026.
- What does net proceeds from sales of subsidiary shares mean?
- Cash received from selling shares of a subsidiary to the public for the first time.
- How do you interpret net proceeds from sales of subsidiary shares?
- An increase indicates a successful divestiture or monetization of a business unit, providing a one-time cash infusion. A decrease or absence of this metric suggests no recent subsidiary IPO activity, which is typical for most established corporations.
- How does net proceeds from sales of subsidiary shares compare across companies?
- This is an infrequent, non-recurring event for most large-cap companies, making it difficult to benchmark against peers unless they are undergoing similar corporate restructuring or portfolio optimization.